PB 61 of 2012
National Health (Price and Special Patient Contribution) Amendment Determination 2012 (No. 5)1
National Health Act 1953
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.
Dated 9 August 2012
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
 
1          Name of Instrument
            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2012 (No. 5).
            (2)        This Instrument may also be cited as PB 61 of 2012.
2          Commencement
            This Instrument commences on 1 September 2012.
3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1     Amendments
 
[1]      Schedule 1, entry for Escitalopram in the form Tablet 10 mg (as oxalate)
(a)           omit from the column headed “Determined Price”:     12.71     substitute:             8.03
(b)           omit from the column headed “Claimed Price”:          16.80     substitute:             10.61
[2]      Schedule 1, entry for Escitalopram in the form Tablet 20 mg (as oxalate)
(a)           omit from the column headed “Determined Price”:     12.79     substitute:             8.10
(b)           omit from the column headed “Claimed Price”:          18.75     substitute:             11.87
[3]      Schedule 1, entry for Meloxicam in the form Tablet 7.5 mg
(a)           omit from the column headed “Determined Price”:     9.60        substitute:             7.33
(b)           omit from the column headed “Claimed Price”:          11.13     substitute:             8.50
[4]      Schedule 1, entry for Meloxicam in the form Tablet 15 mg
(a)           omit from the column headed “Determined Price”:     14.01     substitute:             10.70
(b)           omit from the column headed “Claimed Price”:          15.54     substitute:             11.87
[5]      Schedule 1, entry for Prochlorperazine
(a)           omit from the column headed “Determined Price”:     2.64        substitute:             1.97
(b)           omit from the column headed “Claimed Price”:          5.64        substitute:             4.21
[6]      Schedule 1, entry for Timolol
omit:
 
Eye drops 2.5 mg (as maleate) per mL, 5 mL
Application to the eye
Timoptol
1
4.45
7.09
 
 
 
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.  See http://www.frli.gov.au.